IBRX
Price
$2.40
Change
-$0.01 (-0.41%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
2.13B
93 days until earnings call
IOVA
Price
$2.75
Change
-$0.09 (-3.18%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
918.32M
One day until earnings call
Interact to see
Advertisement

IBRX vs IOVA

Header iconIBRX vs IOVA Comparison
Open Charts IBRX vs IOVABanner chart's image
ImmunityBio
Price$2.40
Change-$0.01 (-0.41%)
Volume$99.62K
Capitalization2.13B
Iovance Biotherapeutics
Price$2.75
Change-$0.09 (-3.18%)
Volume$57.5K
Capitalization918.32M
IBRX vs IOVA Comparison Chart in %
Loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.33B. The market cap for tickers in the group ranges from 58 to 215.92B. NONOF holds the highest valuation in this group at 215.92B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -0%. For the same Industry, the average monthly price growth was 15%, and the average quarterly price growth was 12%. JWCTF experienced the highest price growth at 164%, while VYNE experienced the biggest fall at -75%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was 112% and the average quarterly volume growth was 103%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 57
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -12 (-100 ... +100)

Market Cap

The average market capitalization across the group is 1.52B. The market cap for tickers in the group ranges from 918.32M to 2.13B. IBRX holds the highest valuation in this group at 2.13B. The lowest valued company is IOVA at 918.32M.

High and low price notable news

The average weekly price growth across all stocks in the group was -6%. For the same group, the average monthly price growth was 23%, and the average quarterly price growth was -40%. IBRX experienced the highest price growth at -5%, while IOVA experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the group was 2,885%. For the same stocks of the group, the average monthly volume growth was 81% and the average quarterly volume growth was 67%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 14
P/E Growth Rating: 100
Price Growth Rating: 55
SMR Rating: 98
Profit Risk Rating: 100
Seasonality Score: -50 (-100 ... +100)
VS
IBRX vs. IOVA commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBRX is a Buy and IOVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (IBRX: $2.41 vs. IOVA: $2.75)
Brand notoriety: IBRX and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBRX: 70% vs. IOVA: 56%
Market capitalization -- IBRX: $2.13B vs. IOVA: $918.32M
IBRX [@Biotechnology] is valued at $2.13B. IOVA’s [@Biotechnology] market capitalization is $918.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green whileIOVA’s FA Score has 1 green FA rating(s).

  • IBRX’s FA Score: 1 green, 4 red.
  • IOVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IOVA is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBRX’s TA Score shows that 4 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • IBRX’s TA Score: 4 bullish, 5 bearish.
  • IOVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than IBRX.

Price Growth

IBRX (@Biotechnology) experienced а -5.12% price change this week, while IOVA (@Biotechnology) price change was -6.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.41%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +12.00%.

Reported Earning Dates

IBRX is expected to report earnings on Nov 07, 2025.

IOVA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.13B) has a higher market cap than IOVA($918M). IBRX YTD gains are higher at: -5.859 vs. IOVA (-62.838). IBRX has higher annual earnings (EBITDA): -264M vs. IOVA (-354.01M). IOVA has more cash in the bank: 360M vs. IBRX (61.6M). IOVA has less debt than IBRX: IOVA (53.7M) vs IBRX (526M). IOVA has higher revenues than IBRX: IOVA (213M) vs IBRX (31.2M).
IBRXIOVAIBRX / IOVA
Capitalization2.13B918M232%
EBITDA-264M-354.01M75%
Gain YTD-5.859-62.8389%
P/E RatioN/AN/A-
Revenue31.2M213M15%
Total Cash61.6M360M17%
Total Debt526M53.7M980%
FUNDAMENTALS RATINGS
IBRX vs IOVA: Fundamental Ratings
IBRX
IOVA
OUTLOOK RATING
1..100
6612
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6348
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (3) in the Biotechnology industry is in the same range as IOVA (26). This means that IBRX’s stock grew similarly to IOVA’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IOVA (100). This means that IBRX’s stock grew similarly to IOVA’s over the last 12 months.

IOVA's SMR Rating (97) in the Biotechnology industry is in the same range as IBRX (100). This means that IOVA’s stock grew similarly to IBRX’s over the last 12 months.

IOVA's Price Growth Rating (48) in the Biotechnology industry is in the same range as IBRX (63). This means that IOVA’s stock grew similarly to IBRX’s over the last 12 months.

IOVA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IBRX (100). This means that IOVA’s stock grew similarly to IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IBRXIOVA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMNX28.29N/A
N/A
Harding Loevner International Eq Inv
AVEFX12.31N/A
N/A
Ave Maria Bond
PGPCX26.74N/A
N/A
George Putnam Balanced C
PGJCX17.79N/A
N/A
PGIM Jennison Global Infrastructure C
DESUX24.20N/A
N/A
DWS ESG Core Equity R6

IBRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
N/A
AXON - IBRX
48%
Loosely correlated
+16.41%
ARRY - IBRX
41%
Loosely correlated
-1.50%
RXRX - IBRX
41%
Loosely correlated
-4.66%
CLRB - IBRX
40%
Loosely correlated
-3.75%
VRDN - IBRX
38%
Loosely correlated
+3.44%
More

IOVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-2.83%
PLX - IOVA
49%
Loosely correlated
-5.33%
ROIV - IOVA
44%
Loosely correlated
+1.04%
VCYT - IOVA
43%
Loosely correlated
+2.84%
IDYA - IOVA
42%
Loosely correlated
-3.52%
ADMA - IOVA
42%
Loosely correlated
-4.77%
More